Skip to content

Valiant Navion™ VNMF2828C174TU (UDI 00763000100582)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT VNMF2828C174TU VAL NAV FF · Class 3 · Implant

All models of Valiant Navion (137)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
1
Injuries reported
1
Recalls naming it
1

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000100582), received between Nov 22, 2022 and Jan 23, 2023 — classified as 1 death, 1 injury.

The most frequently reported specific device problem is “Leak/Splash” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 12, 2021Class IOpen, Classified

    Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

    Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Leak/Splash1

Patient problems

  • Cognitive Changes1
  • Insufficient Information1
  • Sepsis1
  • Unspecified Infection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • DeathJan 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A SACCULAR THORACIC AORTIC ANEURYSM. IT WAS REPORTED APPROXIMATELY 8 MONTHS POST THE INDEX PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH AMS. ON EVALUATION SEPSIS WAS SUSPECTED DUE TO A GRAFT INFECTION. THE PATIENT WAS NOTED TO BE A VERY POOR SURGICAL CANDIDATE AND INSTEAD A COURSE OF ANTIBIOTICS WAS CONSIDERED HOWEVER THE PATIENT EXPIRED BEFORE PROGRESSION OF TREATMENT. PER THE PHYSICIAN THE CAUSE OF THE INFECTION AND DEATH ARE UNDETERMINED.

    Patient problems: Cognitive Changes; Sepsis; Unspecified Infection

    MAUDE report 16223487 ↗
  • InjuryNov 22, 2022Leak/Splash; Leak/Splash

    A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR PROCEDURE OF A THORACIC DISSECTION .  IT WAS REPORTED THAT FOLLOW UP CT  THE FOLLOWING MONTH IDENTIFIED A TYPE IA ENDOLEAK. THERE WAS NO STENT FRACTURE , STENT RING ENLARGEMENT OR STENT RING DISPLACEMENT OBSERVED.  INTERVENTION WAS CARRIED OUT WHERE A SECOND VALIANT NAVION WAS IMPLANTED LESS THAN 2 WEEKS LATER TO TREAT THE ENDOLEAK. NO CAUSE PROVIDED. NO ADDITIONAL SEQUELAE WAS REPORTED AND THE PATIENT IS FINE.

    Patient problems: Insufficient Information

    MAUDE report 15841724 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page